These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 17680822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS, Chow KC, Li WY, Liu CC, Wu YC, Huang MH.
    Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
    Gottschlich S, Görögh T, Lippert BM, Niemann AM, Folz BJ, Werner JA.
    Anticancer Res; 1997 Apr; 17(4B):2921-2. PubMed ID: 9329564
    [Abstract] [Full Text] [Related]

  • 9. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E, Balcerska A.
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E, Deneux L, Mosseri V, Jaulerry C, Brunin F, Point D, Validire P, Dubray B, Fridman WH, Rodriguez J.
    Cancer; 1997 Apr 01; 79(7):1401-8. PubMed ID: 9083163
    [Abstract] [Full Text] [Related]

  • 13. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA, Hill RB, Heldman L, Ramakrishnan S.
    Gynecol Oncol; 1997 Jul 01; 66(1):133-7. PubMed ID: 9234933
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel role of metalloproteinase in cancer-mediated immunosuppression.
    Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH.
    Cancer Res; 2001 Jan 01; 61(1):237-42. PubMed ID: 11196168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Serum soluble interleukin 2 receptor in patients with squamous epithelial carcinomas of the upper aerodigestive tract].
    Gottschlich S, Werner JA, Lippert BM, Görögh T, Maune S, Rudert H.
    Laryngorhinootologie; 1995 Aug 01; 74(8):508-11. PubMed ID: 7575904
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
    Kobayashi H, Tagaya Y, Han ES, Kim IS, Le N, Paik CH, Pastan I, Nelson DL, Waldmann TA, Carrasquillo JA.
    Cytokine; 1999 Dec 01; 11(12):1065-75. PubMed ID: 10623432
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.